Literature DB >> 24189651

Transplantation: Complementing donor-specific antibody testing.

Kathryn J Tinckam1, Peter S Heeger.   

Abstract

New data suggest that among kidney transplant recipients, those whose serum contains donor-specific antibodies that bind C1q fare the worst. Although these findings are intriguing, several unanswered questions remain and changing practice to include a C1q binding assay as standard of care in kidney transplantation would be premature.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24189651      PMCID： PMC4090765          DOI： 10.1038/nrneph.2013.234

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

2.  Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.

Authors:  Martin Karpinski; David Rush; John Jeffery; Markus Exner; Heinz Regele; Silvia Dancea; Denise Pochinco; Patricia Birk; Peter Nickerson
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

3.  Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.

Authors:  Adriana Zeevi; John Lunz; Brian Feingold; Michael Shullo; Christian Bermudez; Jeffery Teuteberg; Steven Webber
Journal:  J Heart Lung Transplant       Date:  2012-11-09       Impact factor: 10.247

4.  Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Authors:  Marta Crespo; Alberto Torio; Virginia Mas; Dolores Redondo; Maria J Pérez-Sáez; Marisa Mir; Anna Faura; Rita Guerra; Olga Montes-Ares; Maria D Checa; Julio Pascual
Journal:  Transpl Immunol       Date:  2013-07-29       Impact factor: 1.708

5.  Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.

Authors:  J M Gloor; J L Winters; L D Cornell; L A Fix; S R DeGoey; R M Knauer; F G Cosio; M J Gandhi; W Kremers; M D Stegall
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

Review 6.  The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera.

Authors:  C Weinstock; M Schnaidt
Journal:  Int J Immunogenet       Date:  2012-08-23       Impact factor: 1.466

7.  Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

Authors:  E F Reed; P Rao; Z Zhang; H Gebel; R A Bray; I Guleria; J Lunz; T Mohanakumar; P Nickerson; A R Tambur; A Zeevi; P S Heeger; D Gjertson
Journal:  Am J Transplant       Date:  2013-06-13       Impact factor: 8.086

8.  Complement-binding anti-HLA antibodies and kidney-allograft survival.

Authors:  Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Christof Prugger; Jean-Paul Duong van Huyen; Nuala Mooney; Caroline Suberbielle; Véronique Frémeaux-Bacchi; Arnaud Méjean; François Desgrandchamps; Dany Anglicheau; Dominique Nochy; Dominique Charron; Jean-Philippe Empana; Michel Delahousse; Christophe Legendre; Denis Glotz; Gary S Hill; Adriana Zeevi; Xavier Jouven
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

Review 9.  Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.

Authors:  Chris Wiebe; Peter Nickerson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

10.  The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.

Authors:  Maria Cecilia S Freitas; Lorita M Rebellato; Miyuki Ozawa; Anh Nguyen; Nori Sasaki; Matthew Everly; Kimberly P Briley; Carl E Haisch; Paul Bolin; Karen Parker; William T Kendrick; Scott A Kendrick; Robert C Harland; Paul I Terasaki
Journal:  Transplantation       Date:  2013-05-15       Impact factor: 4.939
  10 in total
  1 in total

1.  Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.

Authors:  Craig J Taylor; Vasilis Kosmoliaptsis; Jessie Martin; Graham Knighton; Dermot Mallon; J Andrew Bradley; Sarah Peacock
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.